Filing Details
- Accession Number:
- 0001127602-21-011017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-17 16:07:11
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-17 16:07:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1140859 | Amerisourcebergen Corp | ABC | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 233079390 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191508 | H Steven Collis | 1300 Morris Drive Chesterbrook PA 19087 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-16 | 18,667 | $88.71 | 216,724 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-16 | 12,783 | $98.24 | 229,507 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-16 | 33,697 | $112.71 | 195,810 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-03-16 | 18,667 | $0.00 | 18,667 | $88.71 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-03-16 | 12,783 | $0.00 | 12,783 | $98.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
93,333 | 2021-11-12 | No | 4 | M | Direct | |
140,623 | 2022-11-11 | No | 4 | M | Direct |
Footnotes
- The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021.
- Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18
- Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19